PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-1840.05%
Negative net income growth while CRON.TO stands at 79.15%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
1.35%
Some D&A expansion while CRON.TO is negative at -9.75%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-20.81%
Negative yoy deferred tax while CRON.TO stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
-12.00%
Both cut yoy SBC, with CRON.TO at -16.40%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
-164.27%
Negative yoy working capital usage while CRON.TO is 106.09%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
16.45%
AR growth while CRON.TO is negative at -250.58%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
-419.33%
Negative yoy inventory while CRON.TO is 1993.10%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-88.44%
Both negative yoy AP, with CRON.TO at -26.88%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
-191.93%
Negative yoy usage while CRON.TO is 134.81%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
8421.81%
Well above CRON.TO's 24.43%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-163.79%
Negative yoy CFO while CRON.TO is 98.45%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
81.11%
CapEx growth well above CRON.TO's 35.26%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
84.61%
Some acquisitions while CRON.TO is negative at -125.87%. John Neff sees competitor possibly pausing M&A or divesting while the firm invests in new deals.
99.61%
Some yoy expansion while CRON.TO is negative at -0.48%. John Neff sees competitor possibly refraining from new investments or liquidating existing ones for immediate cash.
No Data
No Data available this quarter, please select a different quarter.
-97.85%
Both yoy lines negative, with CRON.TO at -16.32%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
98.31%
Lower net investing outflow yoy vs. CRON.TO's 3150.25%, preserving short-term cash. David Dodd would confirm expansions remain sufficient.
90.30%
Debt repayment growth of 90.30% while CRON.TO is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
117.55%
Issuance growth of 117.55% while CRON.TO is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
-117.55%
We cut yoy buybacks while CRON.TO is 21.13%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.